Clinical Trials Directory

Trials / Completed

CompletedNCT02830399

Clinical Trial on Efficacy of rTMS to Improve ECT in Treatment-Resistant Depression

Clinical Trial on Efficacy of Repeated Transcranial Magnetic Stimulation (rTMS) to Improve Electroconvulsive Therapy (ECT) in Treatment-Resistant Depression (TRD): STIMAGNECT Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
56 (actual)
Sponsor
Centre Hospitalier du Rouvray · Other Government
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

It's a prospective, multicentric, randomized, controlled study concerning 56 patients with treatment-resistant depression (TRD). The main objective of this study was to evaluate the efficacy of priming repeated Transcranial Magnetic Stimulation (rTMS) sessions before Electroconvulsive therapy (ECT) for treatment of TRD patients. The primary outcome will be the depressive symptoms intensity measured with the Hamilton Rating Scale For Depression (HAMD-21 items) after 5 ECT. The secondary outcome is to evaluate the safety and most particularly the cognitive effects of this association.

Detailed description

Included patients are adults, aged between 18 and 70 years, with major depression (Hamilton Rating scale for Depression, HAMD ≥ 15). Patients don't have any experience concerning repeated Transcranial Magnetic Stimulation (rTMS). Patients with treatment-resistant depression (TRD) were assigned to two treatment groups in addition to their current pharmacotherapy regimen : one group received 5 active-rTMS before Electroconvulsive therapy (ECT) and the other one received sham-rTMS before ECT. The depressive symptoms and the cognitive functions are evaluated before rTMS, after 5 rTMS and after 5 ECT.

Conditions

Interventions

TypeNameDescription
DEVICEactive rTMS-ECT5 High Frequency (20Hz) rTMS (applicated on the left prefrontal dorsolateral cortex) before 5 bilateral ECT
DEVICEsham rTMS-ECT5 sham rTMS (applicated on the left prefrontal dorsolateral cortex) before 5 bilateral ECT

Timeline

Start date
2016-07-15
Primary completion
2019-07-12
Completion
2019-07-12
First posted
2016-07-12
Last updated
2021-02-18

Locations

3 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02830399. Inclusion in this directory is not an endorsement.